Issue |
E3S Web Conf.
Volume 131, 2019
2nd International Conference on Biofilms (ChinaBiofilms 2019)
|
|
---|---|---|
Article Number | 01017 | |
Number of page(s) | 4 | |
DOI | https://doi.org/10.1051/e3sconf/201913101017 | |
Published online | 19 November 2019 |
Study on anti-tumor activity of itraconazole in colon cancer
Key Laboratory of Industrial Microbiology, Ministry of Education and Tianjin City, College of Biotechnology, Tianjin University of Science and Technology
a Corresponding author: ma_wj@tust.edu.cn, zhousa@tust.edu.cn
Itraconazole is a common antifungal drug, which inhibiting lanosterol 14 alpha-demethylase, interfering with lanosterol convert to ergosterol or cholesterol, thereby affecting the synthesis of fungal cell membranes. In recent years, it has been found that it has anti-cancer effect and is expected to be used to treat a variety of human cancers. Colon cancer is a cancer disease that affects the health of contemporary people and its incidence tends to be younger. In this paper, the effects of itraconazole on proliferation and migration of Caco2 and HT-29 of two kinds of colon cancer cells were detected by MTT, scratch experiment and western blot. The data showed that itraconazole concomitant with increased drug concentration caused cell morphology of colon cancer significantly shrink. MTT experiment showed that it could reduce the survival rate of colon cells and western blot data indicated that it could down-regulation PCNA and MYL9 which are marker genes of proliferation and migration. Furthermore, the cell migration is reduced.
© The Authors, published by EDP Sciences, 2019
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.